Investing Profile
Karl Rothweiler
Your Intro Paths to Karl Rothweiler
Signal uses Gmail to reveal intro paths. Email content is never read.
Sign in with Google →Current Investing Position
Aglaia BioMedical Ventures Partner
Investment Range
$100K - $5.0M
Sweet Spot
$1.5M
Karl Rothweiler is on these Sector & Stage Rankings
Karl Rothweiler's Experience
Founding Investor, Member of the Supervisory Board Inthera Bioscience AG2022 - Present
Founder, Founding Investor, Member of the Supervisory Board Sapreme Technologies BV2016 - Present
Founding Investor, Member of the Supervisory Board Modra Pharmaceuticals2015 - Present
Founding Investor Merus N.V.2005 - Present
Managing Partner Aglaia Oncology Funds2004 - Present
Founder, Founding Investor, Member of the Supervisory Board InteRNA Technologies BV2006 - 2023
Founder, Founding Investor, Member of the Supervisory Board ISA Pharmaceuticals2004 - 2017
Founder, Founding Investor ORCA Therapeutics2005 - 2013
Founding Investor, Member of the Supervisory Board Syntarga2005 - 2011
Founder Entity Holding1995 - 2004
Director Finance Division Capgemini1990 - 1995
Commercial Manager Volmac1983 - 1990
Karl Rothweiler's Education
--
The University of Georgia MBA Business
Nyenrode New Business School BBA Business
Fioretti College
Investors who invest with Karl Rothweiler